Abstract:Imaging flow cytometry (IFC) combines the advantages of flow cytometry (FC) and microscopy to provide detailed morphological insights into platelets. In this study, we evaluated the performance of morphometric features for heparin‐induced thrombocytopenia (HIT) diagnosis. A total of 42 patients with suspected HIT were included: 28 HIT‐positive patients (tested once) and 14 HIT‐negative patients (tested twice). Morphometric features such as size, shape and contrast showed significant changes between resting platelets (negative control, NaCl) and TRAP‐6‐activated platelets (positive control), enabling the detection of platelet activation with IFC. To diagnose HIT, donor platelet‐rich plasma was mixed with patient platelet‐poor plasma in the presence of increasing concentrations of heparin. Subsequently, platelets were labelled with CD62P, an internal marker of platelet activation. Measurements of area, diameter and major axis features reliably identified HIT‐positive patients, with performance levels comparable to those of CD62P expression. This study highlights that IFC is a label‐free, robust and efficient method for detecting platelet activation, offering a promising alternative to conventional functional assays for HIT diagnosis. Summary Heparin‐induced thrombocytopenia (HIT) is an adverse reaction characterized by anti‐PF4‐heparin antibody generation and hypercoagulability. Imaging flow cytometry (IFC) provides a detailed morphological analysis of platelets, which change upon activation. We evaluated IFC‐derived morphometric features to detect platelet activation and developed a functional assay for HIT diagnosis. We analysed blood samples from 42 patients with suspected HIT and extracted platelet size, shape and texture features using IFC. The morphological features were compared with CD62P expression, light transmission aggregometry (LTA) and a serotonin release assay (SRA) in terms of their ability to predict a HIT diagnosis. Five IFC‐derived morphological features (area, circularity, contrast, diameter and major axis) significantly distinguished resting from activated platelets. The major axis feature performed best for HIT diagnosis, with a sensitivity of 89.3% and a specificity of 92.9% versus functional assays (LTA/SRA); this diagnostic performance was similar to that of CD62P expression on the same platelet donors. The area and diameter had similar specificity (92.9%) and a slightly lower sensitivity (85.7%). The morphological features associated with platelet activation might be effective markers for the diagnosis of HIT, matching platelet CD62P expression assay performance. The high‐throughput IFC exploration of platelet activation offers new perspectives in label‐free analysis and time‐saving.

Measurement of procoagulant platelets provides mechanistic insight and diagnostic potential in heparin-induced thrombocytopenia

How to assess hypercoagulability in heparin-induced thrombocytopenia? Biomarkers of potential value to support therapeutic intensity of non-heparin anticoagulation

High sensitivity and specificity of a new functional flow cytometry assay for clinically significant heparin-induced thrombocytopenia antibodies

Proteomic profiling for biomarker discovery in heparin-induced thrombocytopenia

Evaluation of a flow cytometer-based functional assay using platelet-rich plasma in the diagnosis of heparin-induced thrombocytopenia

New laboratory test in flow cytometry for the combined analysis of serologic and cellular parameters in the diagnosis of heparin-induced thrombocytopenia

Whole Blood Procoagulant Platelet Flow Cytometry Protocol for Heparin-Induced Thrombocytopenia (HIT) and Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) Testing

Evaluating Diagnostic Algorithms for Heparin-Induced Thrombocytopenia using Two Combined Automated Rapid Immunoassays

Heparin-activated procoagulant platelet assay: a flow cytometry-based functional test for heparin-induced thrombocytopenia

Evaluating heparin-induced thrombocytopenia: the old and the new

Functional Testing for Heparin-Induced Thrombocytopenia Using Whole Blood Multiplate Impedance Aggregometry

Combination of two complementary automated rapid assays for diagnosis of heparin-induced thrombocytopenia (HIT)

Imaging flow cytometry as a novel approach for the diagnosis of heparin‐induced thrombocytopenia

A comparative study of platelet factor 4-enhanced platelet activation assays for the diagnosis of heparin-induced thrombocytopenia

Absolute Immature Platelet Counts in the Setting of Suspected Heparin-Induced Thrombocytopenia May Predict Anti-Pf4-heparin Immunoassay Testing Results

Novel Strategy to Combat the Procoagulant Phenotype in Heparin-Induced Thrombocytopenia Using 12-LOX Inhibition

Accuracy of the functional, flow cytometer-based Emo-Test HIT Confirm® for the diagnosis of heparin-induced thrombocytopenia

The use of flow cytometry in the diagnosis of heparin-induced thrombocytopenia (HIT)

A Functional Assay for the Determination of Heparin-Induced Thrombocytopenia via Flow Cytometry

Comparison between different laboratory tests for the detection and prevention of heparin-induced thrombocytopenia

Off-the-shelf cryopreserved platelets for the detection of HIT and VITT antibodies